PGE2 suppression of innate immunity during mucosal bacterial infection
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 3, 45
- https://doi.org/10.3389/fcimb.2013.00045
Abstract
Prostaglandin E2 (PGE2) is an important lipid mediator in inflammatory and immune responses during acute and chronic infections. Upon stimulation by various proinflammatory stimuli such as lipopolysaccharide (LPS), interleukin (IL)-1β, and tumor necrosis factor (TNF)-α, PGE2 synthesis is upregulated by the expression of cyclooxygenases. Biologically active PGE2 is then able to signal through four primary receptors to elicit a response. PGE2 is a critical molecule that regulates the activation, maturation, migration, and cytokine secretion of several immune cells, particularly those involved in innate immunity such as macrophages, neutrophils, natural killer cells, and dendritic cells. Both Gram-negative and Gram-positive bacteria can induce PGE2 synthesis to regulate immune responses during bacterial pathogenesis. This review will focus on PGE2 in innate immunity and how bacterial pathogens influence PGE2 production during enteric and pulmonary infections. The conserved ability of many bacterial pathogens to promote PGE2 responses during infection suggests a common signaling mechanism to deter protective pro-inflammatory immune responses. Inhibition of PGE2 production and signaling during infection may represent a therapeutic alternative to treat bacterial infections. Further study of the immunosuppressive effects of PGE2 on innate immunity will lead to a better understanding of potential therapeutic targets within the PGE2 pathway.Keywords
This publication has 98 references indexed in Scilit:
- PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsBlood, 2010
- A Role for IL-1 Receptor-Associated Kinase-M in Prostaglandin E2-Induced Immunosuppression Post-Bone Marrow TransplantationThe Journal of Immunology, 2010
- Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repairNature Immunology, 2009
- Staphylococcus aureusInduces Expression of Receptor Activator of NF-κB Ligand and Prostaglandin E2in Infected Murine OsteoblastsInfection and Immunity, 2008
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathThe Journal of Experimental Medicine, 2008
- Prostaglandin E2Suppresses Bacterial Killing in Alveolar Macrophages by Inhibiting NADPH OxidaseAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2European Journal of Immunology, 2007
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Increased Levels of Inflammatory Mediators in Children and Adults Infected withVibrio choleraeO1 and O139Clinical and Vaccine Immunology, 2002
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984